National Bank of Greece announces interim dividend distribution pending ECB approval

Pavlos Mylonas CEO
Pavlos Mylonas CEO
0Comments

National Bank of Greece S.A. has announced that its Board of Directors approved the distribution of an interim dividend to shareholders for the financial year 2025. The decision was made during board sessions held on September 18 and October 22, 2025.

The total gross amount to be distributed is €200 million, which corresponds to €0.2186 per share. After accounting for treasury shares held by the bank, the final gross amount per share increases to €0.2210.

A tax withholding of 5% will apply in accordance with Article 64 of Law 4172/2013. As a result, most shareholders will receive a net amount of €0.2100 per share unless they are subject to different provisions under Articles 46, 48, or 63 of Law 4172/2013.

The ex-dividend date is set for Monday, November 10, 2025. From this date onward, National Bank of Greece shares will trade on the Athens Exchange without rights to this distribution. Shareholders eligible for the dividend must be registered in the Dematerialized Securities System (D.S.S.), managed by ATHEXCSD, as of Tuesday, November 11, 2025 (record date).

Dividend payments will begin on Friday, November 14, 2025. The designated paying agent is National Bank of Greece S.A., and payments will be made through D.S.S. participants such as banks and brokerage firms according to ATHEXCSD rules and decisions.

For heirs claiming dividends from deceased beneficiaries whose securities are kept in special accounts at D.S.S., payment will be processed once legal documentation is completed.

Uncollected amounts after five years will become time-barred in favor of the Greek State.

The announcement notes that this distribution remains subject to approval by the European Central Bank (ECB).

Shareholders seeking more information can contact National Bank of Greece’s Subdivision for Shareholder Register, General Meetings and Corporate Announcements via email or telephone.

“National Bank of Greece S.A.”, following the Bank’s Board of Directors sessions dated 18 September and 22 October 2025, announces the disposal of an interim dividend to shareholders for the financial year 2025, according to the details described below.

Specifically, a total amount of €200,000,000 (gross amount) or €0.2186 per share (gross amount) shall be distributed to the Bank’s shareholders.

The distributable amount to be paid per share is increased by the amount corresponding to the treasury shares held by the Bank and is finally formed in the gross amount of €0.2210 per share.

From the above gross amount, a corresponding tax of 5% shall be withheld in accordance with Article 64 of Law 4172/2013, as in force and therefore,the net amount that beneficiaries will receive will amount to €0.2100 per share (with exception or variation…for shareholders who are subject to special provisions,such as those under Articles46 ,48,and63of Law4172 /2013).

Ex-Dividend date will be Monday ,10 November2025,and thus from that date on,the shares…will be traded…without right…to receive an amount from above distribution .

Beneficiaries are …shareholders registered …in electronic records …Dematerialized Securities System(DSS)…managed by “ATHEXCSD” on Tuesday ,11November2025(record date ).

Friday ,14November2025 is set as …date …payment …shall commence .

The payment …will be effected through designated paying bank “NationalBankofGreeceSA”,as follows :

1 .Through Participants…in DSS(Banks & Brokerage/Securities Companies),according…provisions…ATHEXCSD Rulebook & relevant decisions .

2 .Especially cases…legal heirs…deceased beneficiaries whose securities kept Special Account their Share DSS managed ATHEXCSD,payment effected following completion legalization heirs .

Amounts – as above – not collected within five years are time-barred in favour Greek State .

It is noted that above distribution subject approval European Central Bank(ECB) .

For any further information ,shareholders may contact Subdivision Shareholder Register General Meetings Corporate Announcements by email [email protected] or calling +30-2103343460,+30-2103343419,+30-2103343422,+30-2103343411.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.